DVA vs PRLB · P/E 14, rev $12.82B vs P/E 75, $1.89B cap
DaVita HealthCare Partners Inc (DVA) versus Proto Labs Inc (PRLB) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Proto Labs Inc (PRLB) is a metal fabrication company listed on NYSE.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
PRLB does not have a complete income-statement cache yet.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. PRLB currently screens at market cap $1.89B and trailing P/E 75.1.
Not investment advice. Open the DVA and PRLB stock pages for the full models.
Not investment advice.